Effects of steroid treatment on activation of nuclear factor κB in patients with inflammatory bowel disease

British Journal of Pharmacology

Volumn 124, Issue 3, 1998, Pages 431-433

  Ardite, E ^c   Panes J ^a,b   Miranda, M ^c   Salas, A ^a   Elizalde, J I ^a   Sans, M ^a   Arce, Y ^b   Bordas, J M ^a   Fernandez Checa J C ^c   Pique J M ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c CSIC   (Spain)

Author keywords

Crohn's disease; Inflammation; Inflammatory bowel disease; Interleukin 8; Nuclear factor B; Steroids; Ulcerative colitis

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; PREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON CROHN DISEASE; COLON MUCOSA; ENTERITIS; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-8; INTESTINAL MUCOSA; NF-KAPPA B; POLYMERASE CHAIN REACTION; PREDNISOLONE; RNA, MESSENGER;

EID: 15444358157     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701887     Document Type: Article

References (12)

1. AUPHAN, N., DIDONATO, J.A., ROSETTE, C., HELMBERG, A. & KARIN, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science, 270, 286-290.
2. BROSTJAN, C., ANRATHER, J., CSIZMADIA, V., STROKA, D., SOARES, M., BACH, F.H. & WINKLER, H. (1996). Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J. Biol. Chem., 271, 19612-19616.
3. CONNER, E.M., BRAND, S. & GRISHAM, M.B. (1996). Inhibition of chronic granulomatous colitis by a selective proteasome inhibitor: antagonist of nuclear transcription factor kB (NF-kB) activation. Gastroenterology, 110, A887.
4. FOLEY, K.P., LEONARD, M.W. & ENGEL, J.D. (1993). Quantitation of RNA using the polymerase chain reaction. Trends Genet., 9, 380-385.
5. HECHT, G. & SAVKOVIC, S.D. (1997). Effector role of epithelia in inflammation-interaction with bacteria. Aliment. Pharmacol. Ther., 11 (Suppl 3), 64-69.
6. JOBIN, C., HASKILL, S., MAYER, L., PANJA, A. & SARTOR, R.B. (1997). Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J. Immunol., 158, 226-234.
7. MUKAIDA, N., OKAMOTO, S., ISHIKAWA, Y. & MATSUSHIMA, K. (1994). Molecular mechanism of interleukin-8 gene expression. J. Leukocyte Biol., 56, 554-558.
8. NEURATH, M.F., PETTERSSON, S., MEYER ZUM BÜSCHENFELDE, K.H. & STROBER, W. (1996). Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit NF-κB abrogates established experimental colitis in mice. Nature Med. 2, 998-1004.
9. SCHEINMAN, R.I., COGSWELL, P.C., LOFQUIST, A.K. & BALDWIN, A.S., Jr. (1995). Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science, 270, 283-286.
10. SCHREIBER, E., MATTHIAS, P., TWUELLER, M.M. & SCHAFFNER, W. (1989). Eucaryotic expression vector for the analyses of mutant proteins. Nucleic Acid Res., 17, 6418-6419.
11. STEIN, B. & BALDWIN, A.S., Jr. (1993). Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperatively between C/EBP and NF-kappa B. Mol. Cell. Biol., 13, 7191-7198.
12. UNLAP, M.T. & JOPE, R.S. (1997). Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo. Brain Res. Mol. Brain. Res., 45, 83-89.